Lignans are accessible to human breast cancer xenografts in athymic mice

Nutrition and Cancer

Volumn 60, Issue 2, 2008, Pages 245-250

  Saarinen, Niina M ^a   Power, Krista A ^a   Chen, Jianmin ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIGNAN; SECOISOLARICIRESINOL; SECOISOLARICIRESINOL DIGLUCOSIDE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BRAIN; BREAST CANCER; CANCER TISSUE; CELL STRAIN MCF 7; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; KIDNEY; LUNG; MOUSE; NONHUMAN; NUDE MOUSE; RADIOACTIVITY; SKIN; SPLEEN; TUMOR VOLUME; TUMOR XENOGRAFT; UTERUS;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; LIGNANS; MICE; MICE, INBRED BALB C; MICE, NUDE; ORGAN SIZE; TRITIUM; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS;

EID: 41349088637     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635580701649669     Document Type: Article

References (38)

1. Piller R, Chang-Claude J, and Linseisen J: Plasma enterolactone and genistein and the risk of premenopausal breast cancer. Eur J Cancer Prev 15, 225-232, 2006.
2. Thanos J, Cotterchio M, Boucher BA, Kreiger N, and Thompson LU: Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control 17, 1253-1261, 2006.
3. Fink BN, Steck SE, Wolff MS, Britton JA, Kabat GC, et al.: Dietary flavonoid intake and breast cancer risk among women on Long Island. Am J Epidemiol 165, 514-523, 2007.
4. McCann SE, Muti P, Vito D, Edge SB, Trevisan M, et al.: Dietary lignan intakes and risk of pre- and postmenopausal breast cancer. Int J Cancer 111, 440-443, 2004.
5. Milder IE, Arts IC, van de Putte B, Venema DP, and Hollman PC: Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr 93, 393-402, 2005.
6. Thompson LU, Boucher BA, Liu Z, Cotterchio M, and Kreiger N: Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer 54, 184-201, 2006.
7. Thompson LU, Robb P, Serraino M, and Cheung F: Mammalian lignan production from various foods. Nutr Cancer 16, 43-52, 1991.
8. Heinonen S, Nurmi T, Liukkonen K, Poutanen K, Wahala K, et al.: In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49, 3178-3186, 2001.
9. Power KA, Saarinen NM, Chen JM, and Thompson LU: Mammalian lignans enterolactone and enterodiol, alone and in combination with the isoflavone genistein, do not promote the growth of MCF-7 xenografts in ovariectomized athymic nude mice. Int J Cancer 118, 1316-1320, 2006.
10. Bergman Jungestrom M, Thompson LU, and Dabrosin C: Flaxseed and its lignans inhibit estradiol-induced growth, angiogenesis, and secretion of vascular endothelial growth factor in human breast cancer xenografts in vivo. Clin Cancer Res 13, 1061-1067, 2007.
11. Chen J, Saggar J, Webster M, and Thompson LU: Component of flaxseed responsible for its ability to regress the growth of established human breast tumors (MCF-7) in ovariectomized nude mice. Proc Am Assoc Cancer Res 48, 1028, 2007.
12. Brooks JD and Thompson LU: Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J Steroid Biochem Mol Biol 94, 461-467, 2005.
13. Sathyamoorthy N, Wang TT, and Phang JM: Stimulation of pS2 expression by diet-derived compounds. Cancer Res 54, 957-961, 1994.
14. Rickard SE and Thompson LU: Chronic exposure to secoisolariciresinol diglycoside alters lignan disposition in rats. J Nutr 128, 615-623, 1998.
15. Rickard SE, Orcheson LJ, Seidl MM, Luyengi LL, Fong HH, et al.: Dose-dependent production of mammalian lignans in rats and in vitro from the purified precursor secoisolariciresinol diglycoside in flaxseed. J Nutr 126, 2012-2019, 1996.
16. Rickard SR and Thompson LU: Urinary composition and postprandial blood changes in 3H-secoisolariciresinol diglycoside (SDG) metabolites in rats do not differ between acute and chronic SDG treatments. J Nutr 130, 2299-2305, 2000.
17. Canadian Council on Animal Care: Guide to the Care and Use of Experimental Animals, Vol 1, 2nd ed. Ottawa, Canada: Canadian Council on Animal Care, 1993.
18. Saarinen NM, Power K, Chen J, and Thompson LU: Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts. Int J Cancer 119, 925-931, 2006.
19. Lankelma J, Dekker H, Luque FR, Luykx S, Hoekman K, et al.: Doxorubicin gradients in human breast cancer. Clin Cancer Res 5, 1703-1707, 1999.
20. Jang SH, Wientjes MG, Lu D, and Au JL: Drug delivery and transport to solid tumors. Pharm Res 20, 1337-1350, 2003.
21. Thompson LU, Seidl MM, Rickard SE, Orcheson LJ, and Fong HH: Antitumorigenic effect of a mammalian lignan precursor from flaxseed. Nutr Cancer 26, 159-165, 1996.
22. Saarinen NM, Huovinen R, Warri A, Makela SI, Valentin-Blasini L, et al.: Enterolactone inhibits the growth of 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in the rat. Mol Cancer Ther 1, 869-876, 2002.
23. Smeds AI, Toivonen TT, Penttinen, PE, Saarinen NM, Sjöholm RE, et al.: The Effects of Diets Supplemented With Defatted Flaxseed or Rye Bran on the Urinary Excretion and Serum Concentration of Lignans in Adult Male and Female Rats. Proceedings of XII International Conference on Polyphenols. Jyväskylä, Finland: Gummerus. 2004, pp 397-398.
24. Saarinen NM, Warri A, Airio M, Smeds A, and Makela S: Role of dietary lignans in the reduction of breast cancer risk. Mol Nutr Food Res, 51, 857-866, 2007.
25. Chen J, Hui E, Ip T, and Thompson LU: Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin Cancer Res 10, 7703-7711, 2004.
26. Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, et al.: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147-153, 1993.
27. Power KA and Thompson LU: Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer? Mol Nutr Food Res, 51, 845-856, 2007.
28. Mueller SO, Simon S, Chae K, Metzler M, and Korach KS: Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci 80, 14-25, 2004.
29. Brooks JD, Ward WE, Lewis JE, Hilditch J, Nickell L, et al.: Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. Am J Clin Nutr 79, 318-325, 2004.
30. Adlercreutz H, Mousavi Y, Clark J, Hockerstedt K, Hamalainen E, et al.: Dietary phytoestrogens and cancer: in vitro and in vivo studies, Steroid Biochem. Mol Biol 41, 331-337, 1992.
31. Lambert JD, Zhao D, Meyers RO, Kuester RK, Timmermann BN, et al.: Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse. Toxicon 40, 1701-1708, 2002.
32. Boccardo F, Lunardi GL, Petti AR, and Rubagotti A: Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk. Breast Cancer Res Treat 79, 17-23, 2003.
33. Hong SJ, Kim SI, Kwon SM, Lee JR, and Chung BC: Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J 43, 236-241, 2002.
34. Rannikko A, Petas A, Rannikko S, and Adlercreutz H: Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestrogen supplementation. Prostate, 66, 82-87, 2006.
35. Bylund A, Saarinen N, Zhang JX, Bergh A, Widmark A, et al.: Anticancer effects of a plant lignan 7-hydroxymatairesinol on a prostate cancer model in vivo. Exp Biol Med (Maywood) 230, 217-223, 2005.
36. Giorda G, Franceschi L, Crivellari D, Magri MD, Veronesi A, et al.: Determination of tamoxifen and its metabolites in the endometrial tissue of long-term treated women. Eur J Cancer, 36, S88-S89, 2000.
37. Kisanga ER, Gjerde J, Guerrieri-Ganzaga A, Pigatto F, Pesci-Feltri A, et al.: Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin Cancer Res, 10, 2336-2343, 2004.
38. Gu L, Laly M, Chang HC, Prior RL, Fang N, et al.: Isoflavone conjugates are underestimated in tissues using enzymatic hydrolysis. J Agric Food Chem, 53, 6858-6863, 2005.